Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2000
03/23/2000CA2342583A1 Fused pyridine inhibitors of cgmp phosphodiesterase
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/22/2000EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit
03/22/2000EP0987264A1 4,4-difluoro-2,3,4,5-tetrahydro-1h-1-benzazepine derivatives and drug compositions containing them
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0986557A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986550A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986545A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
03/22/2000EP0986544A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
03/22/2000EP0986398A1 Method for the production of vaccines against cell surface proteins
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000EP0986389A1 Novel process
03/22/2000EP0986385A1 Antagonists of gonadotropin releasing hormone
03/21/2000US6040340 Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040324 Prophylactic or therapeutic drug for renal diseases
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040309 Benzothiophene derivatives useful in therapy
03/21/2000US6039951 Applying a mixture of chili pepper extract with lubricants, oils, creams
03/21/2000US6039948 Amino acid sequences with beta subunit of chorionic gonadotropin endogenous to mammals
03/16/2000WO2000014231A1 Lim domain protein homolog
03/16/2000WO2000014088A1 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000013664A1 Drug preparations for treating sexual dysfunction
03/16/2000WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000CA2342769A1 Drug preparations for treating sexual dysfunction
03/16/2000CA2341302A1 Lim domain protein homolog
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0984982A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
03/15/2000EP0984980A1 20-ARALKYL-5$g(a)-PREGNANE DERIVATIVES
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984780A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
03/15/2000EP0723453B1 Method of treating reproductive disorders
03/15/2000CN1247470A Method of using cycloxygenase-2 inhibitors as anti-angiogenic agents
03/15/2000CN1247073A Chinese medicine for treating acyesis
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000USRE36617 (Substituted aralkyl) heterocyclic compounds
03/14/2000US6037386 Latex barrier having polymer matrix comprising zinc oxide or zinc gluconate gel irritant deactivating agent; condoms, gloves
03/14/2000US6037346 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis
03/14/2000CA2195213C Use of droloxifene for the treatment of cardiovascular diseases
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
03/09/2000WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
03/09/2000WO2000012504A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342109A1 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341525A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983244A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
03/08/2000CN1246861A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
03/08/2000CN1246356A Fetus-protecting instant particles for treating habitual or threatened abortion
03/08/2000CN1246354A Medicinal composition for treating hyperplasia of mammary gland disease
03/08/2000CN1246345A Medical liquor for nourishing kidney
03/08/2000CN1246343A Snuff for treating mastopathy and its inhalator
03/07/2000US6034246 Anticancer agent
03/07/2000US6034113 Derivatives of 1,3,4-oxadiazolone
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000CA2195093C Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010604A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000WO2000010594A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
03/02/2000WO2000010567A1 Amelioration of apomorphine adverse effects
03/02/2000WO2000010559A1 Inorgasmia treatment
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000DE19838705A1 Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one New dihydro- (1,2,3) triazolo [4,5-d] pyrimidin-7-one
03/02/2000CA2341673A1 Amelioration of apomorphine adverse effects
03/02/2000CA2339800A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000CA2338644A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
03/01/2000EP0981354A1 Condensation polymer composition for preventing pregnancy
03/01/2000EP0981349A1 Pregnan-3-ol-20-ones
03/01/2000EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
03/01/2000EP0981327A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246121A Immunosuppressive compounds and methods
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 557